AMPH

MKT CAP:$812M

Amphastar P

Market Cap

$812M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$19.74-$6.72 (-25.40%)

Jun 5, 2026

52W High $30.8152W Low $16.87

Company Details

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a ...

CEO

—

IPO Date

Jun 25, 2014

Website

www.amphastar.com

Key Metrics TTM

Revenue

$721M

-1.1% YoY

Net Income

$79M

EPS (Diluted)

Free Cash Flow

$135M

Revenue / Share

$15.51

Gross Margin

47.3%

Operating Margin

16.2%

Net Margin

11.0%

FCF Margin

18.8%

P/S

1.1x

P/E

10.3x

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 7, 2026

$171M+0.4%

FY 2025

Feb 26, 2026

$720M-1.7%

Q4 2025

Feb 26, 2026

$183M-1.8%

Q3 2025

Nov 6, 2025

$192M+1.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee